Robert L. Coleman, MD
Robert L. Coleman, MD
Profession

Medical Doctor

Medical Specialty

Oncology

Interests
Novel therapeutics for ovarian, uterine and cervical cancer, clinical trial development and statistical design.

Dr. Coleman has authored and co-authored over 500 scientific publications, including over 260 peer-reviewed articles, numerous book chapters, monographs, invited articles and textbooks including, The Handbook of Gynecologic Oncology, Clinical Lymphatic Mapping in Gynecologic Cancers, Prognostic and Predictive Factors in Gynecological Cancers, and most recently, An Atlas of Gynecologic Oncology. He is a frequently invited lecturer for national and international conferences and meetings where he continues to foster global scientific collaboration. Before returning to MD Anderson, Dr. Coleman served as Division Director of Gynecologic Oncology at Creighton University School of Medicine and Vice-Chairman of Obstetrics and Gynecology at The University of Texas Southwestern Medical Center in Dallas. There he held the inaugural Patricia Duniven-Fletcher Professorship of Gynecologic Oncology.  He is the institution’s Gynecologic Oncology Group (GOG) Principal Investigator (PI) and is PI or Co-PI for several GOG prospective clinical trials including a national, multicenter, randomized trial evaluating chemotherapy and surgery for recurrent ovarian cancer, as well as, numerous investigator-initiated clinical studies of novel chemotherapeutic and biological compounds in cancers of the ovary, cervix and uterus. He has also been involved in three trials evaluating lymphatic mapping for gynecologic malignancies. He currently is a co-Project leader for the MDACC Ovarian SPORE, the MDACC Uterine SPORE, The Ovarian Cancer Research Fund, and the Marcus Foundation, each of which is sponsoring novel therapeutics trials in gynecologic cancers. In addition, recent funding from the Cancer Prevention Research Institute of Texas (CPRIT) will be used to support a first-in-human therapeutics study of systemically delivered siRNAs in patients with solid tumors. Dr. Coleman currently serves on the Editorial Board of several peer-reviewed scientific publications. He is an active member of many national organizations including the Society of Gynecologic Oncology, the American College of Surgeons, American Association for Cancer Research and the American Society of Clinical Oncology.

| https://faculty.mdanderson.org/profiles/robert_coleman.html


Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us